Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 9Brain Neoplasms 6Neoplasms 4Colorectal Neoplasms 4Colonic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Rectal Neoplasms 3Neurotoxicity Syndromes 3Lung Neoplasms 3Glioblastoma 3Small Cell Lung Carcinoma 2Prostatic Neoplasms 2Pain 2Oligodendroglioma 2Medulloblastoma 2Malnutrition 2Lymphoma 2Hematologic Neoplasms 2Gliosarcoma 2Glioma 2Fatigue 2Ependymoma 2Depression 2Craniopharyngioma 2Central Nervous System Neoplasms 2Astrocytoma 2Unspecified Adult Solid Tumor, Protocol Specific 1Teratoma, Ovarian 1Sexuality 1Seizures 1

Interventions

Vincristine 1Therapeutics 1Methotrexate 1Mental Status and Dementia Tests 1Leucovorin 1Filgrastim 1Etoposide 1Doxorubicin 1Dactinomycin 1Cyclophosphamide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Teratoma, Ovarian × Mental Status and Dementia Tests × Clear all
NCT01080521 2018-04-12

Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy

GOG Foundation

Completed
247 enrolled
Gynecologic

Teratoma, Ovarian, Brenner Tumor, Dysgerminoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡